Douni Eleni, Alexiou Maria, Kollias George
Institute of Immunology, Biomedical Sciences Research Center, Vari, Greece.
Methods Mol Med. 2004;98:137-70. doi: 10.1385/1-59259-771-8:137.
With the exponential increase in the number of genes identified by various genome projects, it has become imperative that efficient methods be developed for deciphering gene function. Genetically engineered strains of mice are now critical research tools for basic biomedical research and for genomic approaches for the development of new therapeutic treatments for human disease. Over the past ten years it has become possible to make essentially any mutation in the mouse by transgenesis and homologous recombination in embryonic stem cells. Current advances in the "genetic engineering of the mouse," including the tissue-specific activation or inactivation of gene expression combined with developing technologies for switching gene expression on and off at will, provide experimental settings unprecedented in their potential to offer answers to long-standing questions.
随着各种基因组计划所识别的基因数量呈指数级增长,开发高效的基因功能解读方法变得势在必行。基因工程改造的小鼠品系如今已成为基础生物医学研究以及开发人类疾病新治疗方法的基因组学方法的关键研究工具。在过去十年中,通过胚胎干细胞中的转基因和同源重组,基本上可以在小鼠中制造任何突变。“小鼠基因工程”的当前进展,包括基因表达的组织特异性激活或失活,以及结合可随意开关基因表达的技术发展,提供了前所未有的实验环境,有望为长期存在的问题提供答案。